Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study
Li Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianwei Wang(Zhejiang Cancer Hospital), Chao Wu(Beijing Tongren Hospital), Jingchuan Zhong(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiuyang Xu(Tsinghua University), Guohui Fan(China-Japan Friendship Hospital), Liang Kang(Sun Yat-sen University), Ying Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Geng Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Haibo Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Hong Chen(Shanghai Jiao Tong University), Bin Cao(Shandong Provincial Hospital), Qi Jin(Linyi University), Xiaoying Gu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yeming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yongfeng Hu(Chinese Academy of Medical Sciences & Peking Union Medical College), Linghang Wang(Beijing Ditan Hospital), Lianlian Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaojing Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Lili Ren(Huaibei Normal University), Conghui Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaohui Zou(China-Japan Friendship Hospital)
Cited by 104
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
|The Lancet|2020|29.1k
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k